Pharmaceutical

Fate Therapeutics makes Bob Valamehr president and CEO

Fate has announced the retirement of president and CEO Scott Wolchko with Bob Valamehr set to assume the role from 1 January 2025.

Dec 3, 2024 - 06:00
Fate Therapeutics makes Bob Valamehr president and CEO
Fate has announced the retirement of president and CEO Scott Wolchko with Bob Valamehr set to assume the role from 1 January 2025.
Read the original article

Tags:

Previous Article

Faron Pharma secures UK innovation passport for blood cancer immunotherapy

Next Article

CHMP recommends oral peanut allergy immunotherapy treatment for toddlers  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

U.S. life expectancy rose in 2022, but it remains below...

Nov 29, 2023

Rejuvenate and SAS partner to harness AI for age-related diseases

Rejuvenate and SAS partner to harness AI for age-relate...

Aug 3, 2024

PRO-1107 by ProfoundBio Suzhou for Gastric Cancer: Like...

Apr 21, 2024